Neoplastic (malignant) related neuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with cancer Patients undergoing chemotherapy or Complete chemotherapy in the last two months Patients with complained of neuropathy whose neuropathy is due to chemotherapy with taxane drugs Having symptoms of peripheral neuropathy in all four organs Having at least B grade based on the PNQ questionnaire Having at least 18 years and maximum 80 years
Exclusion criteria
Exclusion criteria: diabetes renal failure Brain metastasis Carpal tunnel syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of neuropathy based on patient's statements. Timepoint: 14, 21 and 28 days after interference. Method of measurement: Neuropathy Severity Scale questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of "The Cancer Neuropathy Scale". Timepoint: The weeks of 0 and 4 after treatment. Method of measurement: The Cancer neuropathy Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences